Skip to content

Measurement of Antioxidant Activity and Oxidative Stress in Patients Undergoing Ophthalmic Surgery.

Effects of Laser Species and Ocular Antioxidant Activity on Postoperative Inflammation, Oxidative Stress and Visual Prognosis in Patients Undergoing Ophthalmic Surgery - a Comparative Study.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06743594
Enrollment
1000
Registered
2024-12-20
Start date
2025-03-14
Completion date
2025-11-30
Last updated
2025-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Myopia

Keywords

antioxidants

Brief summary

This trial hypothesized that novel laser refractive surgery techniques (LASIK, KLEx) or laser-assisted cataract surgery (FLACAS) could suppress postoperative inflammation and improve recovery in patients by reducing oxidative stress generated by the surgical procedure. It is also intended to verify whether the new laser technology is necessary for clinical use in groups with low antioxidant activity through the detection of antioxidant activity in the eyes of patients.

Detailed description

Simultaneously measure total reactive oxygen species (ROS), antioxidant capacity (TAC) and ascorbic acid (AA) in aqueous humor (cataract surgery only) or tears. All patients underwent the same examination at our institution, including uncorrected visual acuity (UCVA), intraocular pressure (IOP), as well as central corneal thickness (CCT) with pneumatic tonometer, apparent refraction with autorefractor, and corneal curvature with keratometer. The axial length (AXL), anterior chamber depth (ACD) and lens thickness (LT) were measured by optical biometer.

Interventions

None listed

Sponsors

Taipei Nobel Eye Clinic
CollaboratorOTHER
Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* at least 20 years old * corneal refractive surgery or cataract surgery patients

Exclusion criteria

* patients with eye infections * presence of severe retinal disease * presence of severe eye injury or severe ptosis

Design outcomes

Primary

MeasureTime frameDescription
ROS in aqueous humor at the next dayBefore the operation and one day after surgery.Change of Reactive Oxygen Species (ROS) in aqueous humor from Baseline to one day after surgery
ROS in tears at 1 monthBefore the operation and 1 month after surgery.Change of Reactive Oxygen Species (ROS) from Baseline to 1 month after surgery.
ROS in tears at 2 monthsBefore the operation and 2 months after surgery.Change of Reactive Oxygen Species (ROS) from Baseline to 2 moths after surgery.
ROS in tears at 3 monthsBefore the operation and 3 months after surgery.Change of Reactive Oxygen Species (ROS) from Baseline to 3 months after surgery.
TAC in aqueous humor at the next dayBefore the operation and one day after surgery.Change of Total Antioxidant Capacity (TAC) in aqueous humor from Baseline to one day after surgery
AA in aqueous humor at the next dayBefore the operation and one day after surgery.Change of Ascorbic Acid (AA) in aqueous humor from Baseline to one day after surgery
TAC in tears at 1 weekBefore the operation and 1 week after surgery.Change of Total Antioxidant Capacity (TAC) from Baseline to 1 week after surgery.
TAC in tears at 1 monthBefore the operation and 1 month after surgery.Change of Total Antioxidant Capacity (TAC) from Baseline to 1 month after surgery.
TAC in tears at 2 monthsBefore the operation and 2 months after surgery.Change of Total Antioxidant Capacity (TAC) from Baseline to 2 months after surgery.
TAC in tears at 3 monthsBefore the operation and 3 months after surgery.Change of Total Antioxidant Capacity (TAC) from Baseline to 3 months after surgery.
AA in tears at 1 weekBefore the operation and 1 week after surgery.Change of Ascorbic Acid (AA) from Baseline to 1 week after surgery.
AA in tears at 1 monthBefore the operation and 1 month after surgery.Change of Ascorbic Acid (AA) from Baseline to 1 month after surgery.
AA in tears at 2 monthsBefore the operation and 2 months after surgery.Change of Ascorbic Acid (AA) from Baseline to 2 months after surgery.
AA in tears at 3 monthsBefore the operation and 3 months after surgery.Change of Ascorbic Acid (AA) from Baseline to 3 months after surgery.
ROS in tears at 1 weekBefore the operation and 1 week after surgery.Change of Reactive Oxygen Species (ROS) from Baseline to 1 week after surgery.

Secondary

MeasureTime frameDescription
UCVA at 1 week1 week after surgeryExamination of uncorrected visual acuity (UCVA)
UCVA at 1 month1 month after surgeryExamination of uncorrected visual acuity (UCVA)
UCVA at 2 months2 months after surgeryExamination of uncorrected visual acuity (UCVA)
UCVA at 3 months3 months after surgeryExamination of uncorrected visual acuity (UCVA)
BCVABefore surgeryExamination of best corrected visual acuity (BCVA)

Countries

Taiwan

Contacts

Primary ContactHung-Chi Chen, PhD
mr3756@cgmh.org.tw+886-975365859
Backup ContactChia-Yi Li, MD
ao6u.3msn@hotmail.com+886-2-27400058

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026